Innovations in Diagnostics - Next generation molecular and point-of-care diagnostics driving personalized healthcare

Diagnostics examines the advances in the rapidly growing field of molecular technologies that are enabling personalized healthcare to move into mainstream medicine. New opportunities in infectious disease testing, molecular oncology and pharmacogenomics are explored in detail, enabling you to understand the forces that are driving in vitro diagnostics (IVDs) into centre stage of the healthcare arena. Understand the changing relationship between IVD companies and the pharmaceutical industry, assess the convergence of IVDs and medical imaging, and develop an understanding of new technologies that will influence diagnostic product development and drug development programs.

This report will provide:

Global market values in 2005 and forecasts to 2010 by IVD sector including molecular, immunoassays, microbiology and point-of-care.

Up-to-date information on merger and acquisition activity and profiles of leading pharmaceutical, medical technology, specialist diagnostic and technology companies competing in the diagnostics sector.

An analysis of key diagnostic technologies and emerging innovations in molecular technology.

An examination of how key trends in the provision of healthcare - such as cost containment and patient power - are influencing the development of new diagnostic products.

Enabling you to:

Discover the IVD sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted success.

Identify the key players in the IVD market, recognize lucrative partnering opportunities and benchmark your strategies against the leading players.

Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users.

Understand the factors driving growth of the point-of-care market, which represents over 30% of global IVD sales.

Understand the changing relationship between IVD companies and the pharmaceutical industry, assess the convergence of IVDs and medical imaging and develop an understanding of new technologies that will influence diagnostic product development and drug development programs.

Published: September 2006 - Format PDF
Table of Contents
Full Table of Contents (PDF)
Price: $2,875.00 / GBP1,897.50